Accessibility Statement
GlaxoSmithKline has an ongoing commitment to ensuring that the content on this website is accessible to the widest range of visitors, regardless of ability.
We believe that this website meets or exceeds the requirements of the level A criteria of the World Wide Web Consortium Web Accessibility Initiative (WCAG WAI) 2.0 guidelines.
Text size
You can vary the text size by using your browser’s text resize option: in many web browsers this can be accessed by selecting View - Text Size or by pressing Ctrl + and Ctrl - on your keyboard.
Alternative text for images
All appropriate images have been given alternative text.
Heading elements
HTML heading elements have been used to represent page structure, supporting assistive technologies that allow page navigation from heading to heading.
Link text
All hyperlinks should make sense when read out of context, and hyperlinks are clearly presented in a different text style from normal body text.
JavaScript independence
Where JavaScript or other scripts are used for navigation or functionality, an alternative mechanism has been put in place in case your browser does not support these scripts.
Colour contrast
We have checked text and background colour combinations to ensure that the contrast is sufficient and we have also ensured that information is not referenced by colour alone.
Style sheets
We have used Cascading Style Sheets (CSS) to control the presentation of pages and have used properly structured markup for content. If style sheets are not supported or are turned off, information on the site can still be accessed and read.
PDFs
In many cases we have provided an HTML version of PDFs on this website, however if you would like to use a screen reader to read PDF documents you can find out more at the Adobe Accessibility Resource Center.
Varilrix® (live attenuated varicella vaccine) is available as an injection. Varilrix is a private-purchase prescription medicine for immunisation and prophylaxis against varicella (chickenpox) in adults and children older than 9 months. You will need to pay for this medicine. Children aged 13 years and older need two doses with an interval between doses of at least 6 weeks. Two doses at least 6 weeks apart are also recommended for children aged between 9 months and 12 years, to provide optimal protection. Use strictly as directed. Do not have a Varilrix injection if you are allergic to Varilrix or to the antibiotic neomycin, if you have a high fever, if you have a condition that causes lack of immunocompetence, or if you are pregnant. Pregnancy should be avoided for 3 months after vaccination. Tell your doctor before you have the vaccine if you have a lowered resistance to disease or have a severe chronic disease. Common side effects: mild rash, a small number of chicken-pox-like blisters, or pain, redness and swelling at the injection site. Uncommon side effects include fever, headache, cough, vomiting, swollen lymph nodes, and joint pain. If you have any side effects, see your doctor, pharmacist, or health professional. Additional Consumer Medicine Information for Varilrix is available at www.medsafe.govt.nz. Prices for Varilrix may vary across doctor's clinics. Normal doctor's office visit fees apply. Ask your doctor if Varilrix is right for you.
Varilrix is a registered trade mark of the GlaxoSmithKline group of companies. Marketed by GlaxoSmithKline NZ Limited, Auckland.
Adverse events involving GSK products should be reported to GSK Medical Information on 0800 808 500.
GSK NZ Limited, Auckland, New Zealand. Updated 01.06.14. TAPS NA 7116/14MY/VAR/0013/13
We cannot answer questions on vaccines through this website or via email.
If you are a patient and have specific questions or information regarding any GSK prescription medicines, please first consult your doctor or healthcare professional. If you have a question about a GSK vaccine or would like to report an adverse event, please call Medical Information on 0800 808 500 or 09 3672900. Contact details for countries other than New Zealand can be found at http://www.gsk.com/contactus.htm
Clicking this link will take you to an independent non GSK site that may contain content that does not necessarily reflect the views of GSK or the licenced indications for the use of GSK products.